NCT02925195View on ClinicalTrials.gov

Individualized Response to Vitamin D Treatment Study

NACompletedINTERVENTIONAL
Enrollment

666

Participants

Timeline

Start Date

January 11, 2017

Primary Completion Date

November 30, 2021

Study Completion Date

March 4, 2022

Conditions
Characteristics That Modify the Response to Cholecalciferol Treatment
Interventions
DIETARY_SUPPLEMENT

Vitamin D3

cholecalciferol (vitamin D3) 2000 IU capsules daily

DRUG

Placebo

Trial Locations (5)

Unknown

University of California, Los Angeles, Los Angeles

Northwestern University, Evanston

John Hopkins University, Baltimore

Columbia Univeristy, New York

Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Washington

OTHER

NCT02925195 - Individualized Response to Vitamin D Treatment Study | Biotech Hunter | Biotech Hunter